דטסקאן

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Koop het nu

Werkstoffen:

IOFLUPANE

Beschikbaar vanaf:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

ATC-code:

V09AB03

farmaceutische vorm:

תמיסה להזרקה

Samenstelling:

IOFLUPANE 74 MBQ/ML

Toedieningsweg:

תוך-ורידי

Prescription-type:

מרשם נדרש

Geproduceerd door:

GE HEALTHCARE B.V., THE NETHERLAND

Therapeutische categorie:

OTHER DOPAMINERGIC AGENTS

Therapeutisch gebied:

IODINE IOFLUPANE (123I)

therapeutische indicaties:

Datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain Parkinsonian Syndromes in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - Datscan is unable to discriminate between Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - To help differentiate probable dementia with Lewy bodies from Alzheimer's disease. Datscan is unable to discriminate between dementia with Lewy bodies and Parkinson's disease dementia

Autorisatie datum:

2014-11-30

Documenten in andere talen

Bijsluiter Bijsluiter Engels 17-08-2016
Productkenmerken Productkenmerken Engels 16-12-2021
Openbaar beoordelingsrapport Openbaar beoordelingsrapport Engels 16-12-2021

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten